Article
The usefulness of CD4/CD8 ratio evaluation in monitoring of ovarian cancer patients.
European journal of gynaecological oncology - 1 Jan 1995
Markowska J, Lacki J K, Jaroszewski J, Wiktorowicz K
Abstract excerpt
Twenty-seven ovarian cancer patients were observed for twenty-four months. The patients were grouped as follows: Group I-with complete (CR) or partial remission (PR), Group II-with stable disease (SD), Group III-with progression (PD) of the disease. In all patients, T lymphocyte phenotypes were estimated in peritoneal fluid (PF) and in peripheral blood (PB). No differences were observed in either PF and PBT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
